E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease - Wikidata - wikimedia - TriplyDB

E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease

E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease

http://www.wikidata.org/entity/Q34506439

about

Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions.Validation of Serological Antibody Profiles Against Human Papillomavirus Type 16 Antigens as Markers for Early Detection of Cervical Cancer.Model systems of human papillomavirus-associated disease.Detection of Papillomavirus Gene Expression Patterns in Tissue Sections.Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients.Potential Role of E4 Protein in Human Papillomavirus Screening: a Review Serum Immune Profiling for Early Detection of Cervical Disease.Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and Maturation.Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples

P2860

Q28078631-33A8C020-DB42-4C04-A2AD-0DF6489BAB3F Q35811067-332FBCD0-A9BF-4151-918F-568445913275 Q36159360-14D72A12-5054-4FA2-83F4-BB00444BFBD2 Q36312170-CC85A2C7-DD25-44EE-ACE8-2A49AE359D6A Q36581107-0C5DA1FC-3922-4052-BF6C-53F9D3175CCC Q38604326-DD366251-04B0-447E-8443-10E5EEA76B3C Q40684530-63B2A10F-DEC8-4B1C-8D2B-7DCB1F87B0E1 Q42245249-4603BFB7-7522-42CB-A865-ACF8F7FDA2B7 Q42343538-2362A400-32ED-41B4-B20B-75BA99ADDD7F Q47094618-1825BB45-BB6E-4FB9-AD07-04A132BF3875 Q47108460-FE16B737-42B1-45EF-B0F8-6604D49E9598 Q58692101-04A484A3-88E5-4532-986A-5AA243420B75

P2860

E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease

http://www.wikidata.org/entity/Q34506439

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

E4 antibodies facilitate detec ...... infection in cervical disease

@ast

E4 antibodies facilitate detec ...... infection in cervical disease

@en

E4 antibodies facilitate detec ...... infection in cervical disease

@nl

type

label

E4 antibodies facilitate detec ...... infection in cervical disease

@ast

E4 antibodies facilitate detec ...... infection in cervical disease

@en

E4 antibodies facilitate detec ...... infection in cervical disease

@nl

prefLabel

E4 antibodies facilitate detec ...... infection in cervical disease

@ast

E4 antibodies facilitate detec ...... infection in cervical disease

@en

E4 antibodies facilitate detec ...... infection in cervical disease

@nl

P1433

Q34506439-372D9261-BAFF-4B8A-862F-229B6870E048

P1476

Q34506439-11635CBD-3CD9-4A1B-945C-501D2262EB78

P2093

Q34506439-3B2A164C-C0FA-4197-A563-BDD119FDA7AB

Q34506439-4A08AC24-9156-4BE9-9F3B-D438559EB7F6

Q34506439-830995B7-3D07-4110-A16B-A9FD124E2C92

Q34506439-908C382B-ED71-48DC-9CE4-303168F62F08

Q34506439-B6E3C283-5C31-453C-8385-D798712719A9

Q34506439-C0849F62-8E2A-4A0C-8177-EA876BAC2F4D

Q34506439-CFE299DA-A4DC-4CF1-8EDD-BB6EC8CE49B3

Q34506439-E191B047-F83F-448F-BB3A-BC6372BC145F

Q34506439-E61CFBFC-6504-4E63-80F9-F733EF8C4EEA

Q34506439-F1956ED1-A7A3-457E-BB95-9639DB160F43

P2860

Q34506439-0DAD185A-70F0-4686-93A1-314FDEE92694

Q34506439-0FA94017-3BDA-4824-BAFB-C20602F46AD5

Q34506439-112FEA74-EF26-469B-9C23-9BC784CFF8BE

Q34506439-1361EBE7-C578-4FF7-8FD0-DAE130539A22

Q34506439-327251D7-86FF-403B-BEB1-0608F6487B46

Q34506439-338F89AC-D65E-441D-A02B-E337B372776C

Q34506439-3615748D-A15A-4C59-9989-E10C6F2D11CD

Q34506439-39212D97-2C39-4C7A-82D4-6B84D9172A74

Q34506439-45EFE0A9-DAB7-4AD7-92E2-F9F6157E7BAE

Q34506439-57E65E17-5863-446D-9C79-33667FDBEF8F

P304

Q34506439-75B3CA8A-5CCB-43BA-99C7-611B8BCFF4CB

P31

Q34506439-908F5EB5-198A-4457-8BAB-FEB61DA2709D

P356

Q34506439-A028137A-9E01-4C26-93BB-350EBBE483B1

P407

Q34506439-9D11146A-ECBB-4600-BC9E-0B5A1678FF74

P433

Q34506439-82217378-CC95-4D2D-9F07-9EAECE81F992

P478

Q34506439-E40D77C1-41F5-4BEF-8686-5788BB9E5DAC

P50

Q34506439-57E9110C-A607-4C1A-A6DC-900B42ADF23E

P577

Q34506439-5DA0938B-BEAE-402F-9833-83C76E46BF3D

P5875

Q34506439-2376CFE3-0DAC-41D0-9CCA-C17DF30925A1

P698

Q34506439-893026BD-2643-4625-8A1A-A1196FFC2E80

P921

Q34506439-AD8B3532-FAC0-4D12-A64E-2106CC46EB25

P932

Q34506439-E4A47720-CC59-4650-8EC1-716FD785FC32

P356

JOURNAL.PONE.0049974

P1433

P1476

E4 antibodies facilitate detec ...... infection in cervical disease

@en

P2093

Anco Molijn

http://www.w3.org/2001/XMLSchema#string

Brigitte Colau

http://www.w3.org/2001/XMLSchema#string

Christine Van Hoof

http://www.w3.org/2001/XMLSchema#string

David Jenkins

http://www.w3.org/2001/XMLSchema#string

Heather Griffin

http://www.w3.org/2001/XMLSchema#string

John Doorbar

http://www.w3.org/2001/XMLSchema#string

Rebecca Marnane

http://www.w3.org/2001/XMLSchema#string

Vincent Dewar

http://www.w3.org/2001/XMLSchema#string

Wim Quint

http://www.w3.org/2001/XMLSchema#string

Zhonglin Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers in cervical cancer screening

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

The papillomavirus life cycle

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

E1--E4-mediated keratin phosphorylation and ubiquitylation: a mechanism for keratin depletion in HPV16-infected epithelium.

Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes.

Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus

One virus, one lesion--individual components of CIN lesions contain a specific HPV type.

P304

e49974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0049974

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233889119

http://www.w3.org/2001/XMLSchema#string

P698

23226504

http://www.w3.org/2001/XMLSchema#string

P921

P932

3513315

http://www.w3.org/2001/XMLSchema#string